RevTek Capital Review: RBF Rates, Terms & Alternatives

What is RevTek Capital?

RevTek Capital is a U.S. growth-debt firm founded in 2021 by Scott Peters (Founder & CEO) and Stephanie Klein, headquartered in Mesa, Arizona with a secondary office in New York. The firm provides bespoke senior-secured debt facilities to recurring-revenue SaaS, AI, healthcare-tech, fintech, and consumer companies. Per revtekcapital.com/our-approach, RevTek writes checks of $2M to $20M+ to companies generating $5M+ in ARR with 50%+ gross margin.

RevTek is a continuation and rebrand of Scott Peters' earlier specialty finance firm WISPer Ventures, LLC (per CBInsights). In August 2021, RevTek announced a $250 million committed debt fund partnership with Chicago Atlantic Group to underwrite recurring-revenue businesses. The firm operates as an SEC-registered investment adviser through RevTek Advisors, LLC (CRD 332452). Per revtekcapital.com/our-story, RevTek has deployed $200M+ in credit across approximately 30 portfolio companies and founders have realized $850M+ in exit value from RevTek-backed companies.

Per revtekcapital.com/faqs, RevTek facilities run 36 to 48 months “depending on the company's trajectory and optimal exit timing,” with interest-only periods and “low amortization” structures to preserve growth cash. RevTek does not publish a public rate card — each transaction is priced bespoke. Notable disclosed deals include the $30 million debt financing to Cymbiotika (October 2024).

Founders searching for RevTek alternatives typically cite the $5M ARR floor, the bespoke no-rate-card pricing model, and the 6–8 week diligence timeline as the primary reasons to evaluate other options. Non-dilutive providers like Founderpath serve recurring-revenue founders earlier in their lifecycle (from $100K ARR on the RPA, $3M+ ARR on the Term Loan) with published starting rates and funding in under 24 hours.

How RevTek Capital Works

RevTek originates senior-secured term debt against the underlying $250M Chicago Atlantic committed debt fund. Borrowers receive bespoke uni-tranche facilities of $2M–$20M+, with terms of 36 to 48 months. Per the Our Approach page, RevTek structures include “interest-only periods” and “low amortization” — explicitly designed to keep monthly cash pay minimal during the growth phase of the facility.

The RevTek process begins with an initial conversation that can happen “within days,” followed by full due diligence and underwriting. Per the RevTek FAQ, “full due diligence and funding is typically completed within 6–8 weeks for qualified opportunities.” The Our Approach page emphasizes “close in under a month” for initial deals and “follow-on funding in less than ten days” for existing borrowers.

RevTek does not publish a public rate card. Pricing — interest rate, origination fee, warrant coverage, success fee, prepayment terms — is negotiated bespoke and disclosed only during diligence. This is meaningfully different from peer senior-secured growth-debt providers like SaaS Capital, who publish 13–16%/yr interest rates and 1–1.5% commitment fees on their public site. Founders considering RevTek should be prepared to invest several weeks of diligence time before learning the all-in cost.

By contrast, Founderpath publishes starting rates (7% flat scaling per year on the Revenue Purchase Agreement / 14% APR on the Term Loan) and underwrites entirely through automated integrations with billing, banking, and accounting platforms. Funds arrive in under 24 hours — no manual document submissions, no in-person visits, no multi-week underwriting cycles.

Why Founders Look for RevTek Alternatives

• 1.$5M ARR floor locks out most SaaS companies. RevTek's public Our Approach page lists $5M+ ARR as a hard requirement. That excludes the entire pre-$5M ARR bootstrapped SaaS market — companies with $1M–$4M ARR that need senior-secured debt but don't qualify for RevTek. Founderpath's Revenue Purchase Agreement underwrites from $100K annual revenue, and the Term Loan is available from $3M+ ARR.
• 2.No published rate card. RevTek does not disclose interest rates, origination fees, warrant coverage, success fees, or prepayment penalties on revtekcapital.com or in any third-party SaaS-finance review. Each deal is priced bespoke and disclosed only during diligence — meaning founders must invest weeks of underwriting time before learning the all-in cost of capital. SaaS Capital, by contrast, publishes 13–16%/yr; Founderpath publishes 7% flat (RPA) / 14% APR (Term Loan).
• 3.6–8 week diligence timeline. RevTek's own FAQ states full DD takes 6–8 weeks. For founders closing a hiring window, responding to competitive pressure, or capitalizing on a short-cycle growth opportunity, this is a real constraint. Founderpath funds in under 24 hours via automated diligence.
• 4.$2M minimum tranche size. RevTek's smallest facility is $2M. Founders looking for $250K–$1.5M in non-dilutive capital are outside RevTek's underwriting band entirely. Founderpath's RPA scales from $100K+ in annual revenue, with facility sizes that match the borrower's revenue profile.
• 5.Manual underwriting. RevTek uses traditional credit-analyst underwriting: data rooms, financial models, management calls, reference checks, in-person diligence at the target's discretion. Founderpath uses direct API integrations into Stripe, QuickBooks, Xero, Plaid, and other billing/banking/accounting platforms — automated review of real-time financial data instead of manually submitted PDFs.
• 6.Contract terms not publicly disclosed. RevTek does not publish details on personal guarantee policy, UCC-1 / collateral specifics, financial covenants, default acceleration mechanics, prepayment penalties, or anti-stacking provisions. Senior-secured term debt typically requires a UCC-1 filing, full asset security interest, and operational covenants — but the specifics negotiated with RevTek are deal-by-deal. Founderpath publishes its product terms: no personal guarantee, no covenants on any product, no prepayment penalty on the Term Loan.
• 7.U.S.-focused. RevTek's portfolio composition (per revtekcapital.com/portfolio) is U.S.-headquartered. International SaaS founders in Europe, LATAM, and APAC are effectively excluded. Founderpath funds SaaS companies worldwide.

Top 6 RevTek Capital Alternatives for SaaS Founders in 2026

The most relevant RevTek alternatives for SaaS founders are non-dilutive lenders that fund recurring-revenue businesses. Below we compare the top alternatives on pricing transparency, ARR minimum, and funding speed.

Founderpath is the only alternative on this list with three non-dilutive products — Merchant Cash Advance, Revenue Purchase Agreement (RPA from a 7% flat discount fee scaling per year), and Term Loan (from 14% APR) — published starting rates, funding in under 24 hours, and underwriting from $100K in annual revenue. Founders comparing RevTek also evaluate Founderpath vs SaaS Capital, Founderpath vs Lighter Capital, and Founderpath vs River SaaS Capital.

Pros and Cons of RevTek Capital

RevTek Capital Pricing Explained

RevTek does not publish a public rate card. No interest rate, origination fee, warrant coverage, success fee, or prepayment penalty is disclosed on revtekcapital.com or in any third-party SaaS-finance review (Lendio, NerdWallet, MerchantMaverick, FunderIntel). Each deal is priced bespoke and disclosed during the 6–8 week diligence process.

What RevTek does publish: 36–48 month terms (revtekcapital.com/faqs), $2M–$20M+ check sizes (revtekcapital.com/our-approach), interest-only periods with “low amortization” repayment structure, no required board seat, $5M+ ARR with 50%+ gross margin underwriting threshold, and 6–8 week diligence timeline. Everything else — interest rate, origination fee, warrant coverage, success fee, commitment fee, legal/closing costs, personal guarantee, collateral specifics, covenants, prepayment terms — is negotiated bespoke and disclosed only inside the term sheet.

The practical consequence is that founders evaluating RevTek cannot pre-screen the all-in cost of capital. A RevTek term sheet arrives 6–8 weeks into the process, after data-room submission, management calls, and underwriting. If the priced rate is uncompetitive with peer offers, founders have already invested several weeks of diligence time. The closest peer benchmark for what RevTek might price is SaaS Capital's published 13–16%/yr range plus a 1–1.5% commitment fee plus a penny warrant, but RevTek may price higher, lower, or differently structured.

Founderpath publishes its pricing on the product pages. The Revenue Purchase Agreement starts from a 7% flat discount fee scaling per year (so a 12-month RPA costs 7% of the funded amount; a 24-month RPA costs 14%). The Term Loan starts at 14% APR with optional interest-only periods. No origination fee, no commitment fee, no warrants, no closing costs on any product.

Is Founderpath Cheaper Than RevTek?

Because RevTek does not publish a rate card, an exact cost comparison requires modelingRevTek at the senior-secured growth-debt industry-band APR (13–16%/yr) and comparing against Founderpath's published starting rates. Using $3M of principal over 36 months — comfortably inside both RevTek's $2M minimum tranche size and Founderpath's “up to $5M+” product cap, and matching the FP RPA 36-month maximum for apples-to-apples:

* RevTek does not publish rates. Modeled at 14%/yr — a mid-range point inside the standard senior-secured growth-debt band (13–16%/yr, per SaaS Capital's published range on saas-capital.com/our-approach as the closest direct peer). Origination, warrants, and commitment fees are not disclosed on revtekcapital.com and would add additional cost on top of interest. Founderpath RPA at a 7% flat discount fee scaling per year (RPA maximum term is 36 months); Founderpath Term Loan at a conservative 16% APR (actual published starting rate is 14%). Actual RevTek terms may differ; verify directly before signing.

At the modeled 14%/yr rate over 36 months, Founderpath's RPA saves roughly $630K+ on $3M of principal, and Founderpath's Term Loan saves roughly $463K+ while fully amortizing the principal. RevTek facilities can also extend to 48 months — at that longer term, FP RPA stays capped at 36 months (its maximum) while FP Term Loan can match the 48-month term, and both Founderpath products typically remain cheaper than RevTek at the modeled midpoint. Both Founderpath products eliminate the bespoke-pricing risk: you know the all-in cost before you sign.

Use the cost calculator below to model your specific principal, modeled APR, and term — and see RevTek's cost at every point of the 13–16%/yr industry band against Founderpath's published rates.

RevTek Capital Reviews (2026)

RevTek Capital does not maintain an active public review profile on Trustpilot, G2, BBB, or Capterra. The closest third-party perspectives come from editorial press coverage of disclosed deals: the PR Newswire release on the $30M Cymbiotika financing (October 2024), independent confirmation by ABF Journal and Pulse2, and the PR Web release on the $250M Chicago Atlantic partnership (2021). Founders evaluating RevTek typically reference-check with current and former portfolio CEOs directly rather than relying on review sites.

What Founders Say About Founderpath

David Tabachnikov

Founder of ScholarshipOwl

After trying all the RBF platforms, Founderpath had the best terms

“After trying all the RBF platforms out there, we found Founderpath to be the best one to work with...”

Jacob Wright

Founder of Dabble

Longer terms than others, and a personal touch

“I've had dealings with Pipe and Capchase, and Founderpath has been the best experience. Longer and more flexible terms, allowing you to pay off early if needed without penalty like the others.”

RevTek Capital Overview

RevTek Capital Funding, Capital Structure & Investors

RevTek Capital does not raise venture equity for the firm itself. Instead, the company operates as an SEC-registered investment adviser (RevTek Advisors, LLC, CRD 332452) and originates loans against a $250 million committed debt fund partnership with Chicago Atlantic Group, announced in August 2021. RevTek does not publish a current portfolio count or aggregate facility size for individual deals beyond the disclosed milestones.

RevTek's capital structure — single warehouse lender (Chicago Atlantic) providing underlying debt capital, RevTek originating and servicing the loans — is unusual in the SaaS financing market. SaaS Capital operates as a series of closed-end LP funds; Lighter Capital is venture-backed with a warehouse line. RevTek's model concentrates underwriting risk and servicing relationship with one originator while sourcing capital from a single institutional partner. Founders should be aware that RevTek's ability to deploy is structurally tied to Chicago Atlantic's ongoing commitment; for very large or atypical facilities, this single-source dependency can be material.

Founderpath vs RevTek: Which Is Right For You?

RevTek Capital is best suited to $5M+ ARR recurring-revenue companies that want a single, long-tenor (36–48 month) senior-secured facility of $2M–$20M+ from a bespoke-priced lender with interest-only periods and a no-board-seat policy. The firm's strengths are its long terms, its large single-tranche check sizes, its $250M Chicago Atlantic backing, and its disclosed track record of $200M+ deployed and $850M+ in exit value created.

However, RevTek's combination of the $5M ARR floor, $2M minimum tranche, 6–8 week diligence timeline, and no-public-rate-card pricing make it a poor fit for:

• Founders with $100K–$5M in annual revenue — outside RevTek's underwriting band
• Founders who want to know their all-in cost before committing 6–8 weeks to diligence
• Founders who need capital quickly — Founderpath funds in under 24 hours
• International SaaS teams — RevTek's portfolio is U.S.-focused
• Founders who prefer fully amortizing repayment to interest-only with a balloon
• Founders looking for sub-$2M facilities

Founderpath offers three non-dilutive products: a Merchant Cash Advance (% of monthly sales, for seasonal cash flows), a Revenue Purchase Agreement (12–36 months, fixed payments, from a 7% flat discount fee scaling per year), and a Term Loan (12–48 months, from 14% APR, optional interest-only periods, no prepayment penalty). All three are available worldwide, require no warrants, no covenants, no board seat, no office visits, and fund in under 24 hours.